Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]
Caffaratti M +9 more
europepmc +1 more source
[Arthritis secondary to tirzepatide. Case report]. [PDF]
Martín Correa E +2 more
europepmc +1 more source
[Pharmacovigilance of vaccines against COVID-19 in community pharmacies. Results with the first dose]. [PDF]
Mera-Gallego R +7 more
europepmc +1 more source
[Pharmacovigilance of vaccines against COVID-19 in community pharmacies. Results after the second dose and comparison between both]. [PDF]
Mera-Gallego R +7 more
europepmc +1 more source
[Adverse drug reactions and letters to the editor]. [PDF]
Garcia Llopis P +2 more
europepmc +1 more source
Reacciones adversas musculoesqueléticas a bifosfonatos
Justificación A través de los programas de notificación espontánea de varios países se han identificado distintas reacciones adversas musculoesqueléticas asociadas al uso de bifosfonatos. Aunque la mayor parte de reacciones son conocidas, su frecuencia, gravedad y factores de riesgo son desconocidos, así como los factores específicos que se ...
openaire +1 more source
[Nocturnal continuous subcutaneous infusion of apomorphine in advanced Parkinson's disease: a series of 37 cases]. [PDF]
García-Fernández C +4 more
europepmc +1 more source
[Patients with adverse drug reactions have a higher prevalence of emotional disorders]. [PDF]
Gutiérrez-Islas E +6 more
europepmc +1 more source
[Treatment adherence and resilient personality in polymedicated over-65s]. [PDF]
Cortes-Fernandez ME +3 more
europepmc +1 more source
[Drug shortages in Family Medicine practice]. [PDF]
Esteban-Jiménez Ó +1 more
europepmc +1 more source

